Abstract:Abstract Background: In the treatment of lung diseases, drug showed low bioavailability and efficacy by conventional administration methods. Passive lung-targeting microspheres provide a method to deliver drugs from the vascular side, there is still a paucity of systematic studies on the biocompatibility of biodegradable-polymer microspheres. Results: We used poly (lactic acid-glycolic acid) (PLGA) microspheres with different particle sizes (3, 10, 25, and 40 mm) as a model. The optimal lung-targeting particle size of the PLGA microspheres is 10 mm and the corresponding range of maximum tolerated dose is 125-150 mg/kg. We hypothesized that the decrease of blood oxygen saturation under treatment of microspheres was caused by pulmonary embolism. We found varying degrees of blood circulation loss of lungs by micro computed tomography test, which indicated severe pulmonary embolism subsequent to intravenous injection of microspheres with a particle size >25 mm. Furthermore, we found lung injury and microspheres leaked from the blood vessels into the alveoli by H&E staining. This process was likely induced by increased secretion of matrix metalloproteinases (MMPs), which destroyed the alveolar-capillary barrier and trigger an inflammatory cascade. Finally, we found that optimal particle size and dose conditions did not affect normal physiological activities after the microspheres degraded. The upregulation of vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule-1 (PECAM-1 or CD31) induced vessel recanalization and reestablishment, which promoted the progress of lung repair. Conclusions: Collectively, our results highlight the importance of accurately designing the optimal size and dose of microspheres for passive lung-targeting delivery.

Preparation and characterization of lung-targeting cefquinome-loaded PLGA microspheres

Preparation and Testing of Cefquinome-Loaded Poly Lactic-Co-glycolic Acid Microspheres for Lung Targeting.

Preparation and Characterization of Three Types of Cefquinome-Loaded Microspheres

Cefquinome-loaded Microsphere Formulations Against Klebsiella Pneumonia Infection During Experimental Infections.

Cefquinome-loaded Microsphere Formulations Againstklebsiella Pneumoniainfection During Experimental Infections

A Comparison of Two Methods for the Preparation Cefquinome-Loaded Gelatin Microspheres for Lung Targeting

Preparation and characterization of lung-targeting ceftiofur-loaded gelatin microspheres.

Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats

Preparation of PLGA Ceftiofur Hydrochlorate Lungtargeted Microsphere with Spray Drying Process

Pharmacokinetics and Tissue Distribution of Cefquinome Sulfate in Rats After I. V. Administration of Liposomal and Injectable Formulations

Preparation of Lung Targeting Azithromycin Liposomes and Its Tissue Distribution in Mice

Preparation and in Vitro Evaluation of Etoposide-Loaded PLGA Microspheres for Pulmonary Drug Delivery.

Preparation and Evaluation of Cefquinome-Loaded Gelatin Microspheres and the Pharmacokinetics in Pigs.

Studies on the Poly(lactic-Co-glycolic) Acid Microspheres of Cisplatin for Lung-Targeting.

Effect of Sizes on the Lung-Targeting and Biocompatibility of Intravenously Administered Biodegradable PLGA Microspheres

Design of gefitinib-loaded PLGA microspheres via microfluidics for lung cancer

Preparation and Characterization of Curcumin Loaded Gelatin Microspheres for Lung Targeting

Preparation,in vitro and in vivo evaluation of actively lung targetable microspheres for paclitaxel delivery

Plga Microspheres as a Delivery Vehicle for Sustained Release of Tetracycline: Biodistribution in Mice After Subcutaneous Administration

Preparation and Characterization of Cefquinome Sulfate Microparticles for Transdermal Delivery by Negative-Pressure Cavitation Antisolvent Precipitation

Preparation of Pingyangmycin Plga Microspheres and Related in Vitro/In Vivo Studies